Metadata
| Status | done |
|---|---|
| Assigned | agent-28 |
| Agent identity | 3184716484e6f0ea08bb13539daf07686ee79d440505f1fdf2de0357707034c3 |
| Model | claude-opus-4-6 |
| Created | 2026-04-01T14:55:55.739310577+00:00 |
| Started | 2026-04-01T14:55:57.813678687+00:00 |
| Completed | 2026-04-01T14:58:42.548915288+00:00 |
| Tags | verification, agency, eval-scheduled |
| Eval score | 0.86 |
| └ blocking impact | 0.86 |
| └ completeness | 0.92 |
| └ coordination overhead | 0.76 |
| └ correctness | 0.90 |
| └ downstream usability | 0.89 |
| └ efficiency | 0.68 |
| └ intent fidelity | 0.62 |
| └ style adherence | 0.87 |
Description
FLIP Verification & Repair
FLIP score 0.62 is below threshold 0.70 — independently verify and, if needed, fix this task's work.
Your Authority
You are a senior engineer reviewing a junior's PR. You have full authority to:
- Edit source files, run builds, run tests, and commit fixes
- Correct mistakes, resolve test failures, and improve the implementation
- Only reject (fail) the source task if the approach is fundamentally wrong
Fix first, fail last. If the work is close but has issues, repair it yourself.
Original Task
ID: research-equity-grant Title: Research: equity grant to Vaughn's Singapore entity instead of individual Description:
Objective
Research the implications and mechanics of issuing Poietic, Inc. Class A equity to a Singapore-registered company (e.g., a consulting entity owned by Vaughn Tan) rather than to Vaughn personally.
Context
- Read
docs/non-us-equity-research.mdfirst — this is a follow-up to that research - Poietic, Inc. is a Delaware PBC
- Vaughn Tan is Singapore-based, may not have a US SSN
- Instead of issuing 4M Class A shares directly to Vaughn personally, the idea is to issue them to a Singapore company that Vaughn owns/controls (e.g., his consulting company)
- This is NOT about making it a subsidiary of Poietic — it would be an independent entity receiving an equity grant
- The goal is to find a simpler compliance path than issuing directly to a non-US individual
Questions to Answer
1. Corporate Structure
- What type of Singapore entity would work? (Pte Ltd? Sole proprietorship?)
- Does Vaughn already need to have this entity, or could one be formed for this purpose?
- Any issues with a Singapore entity holding US corporate equity?
2. US Tax & Compliance (Poietic's Side)
- How does issuing stock to a foreign entity differ from issuing to a foreign individual?
- W-8BEN-E (entity version) vs W-8BEN (individual) — what changes?
- FATCA implications for a foreign entity shareholder?
- Does this simplify or complicate withholding obligations?
- Is Poietic at risk of CFC (Controlled Foreign Corporation) or PFIC issues in reverse?
- Any transfer pricing considerations?
3. Section 83(b) & Vesting
- Does Section 83(b) apply when stock is issued to an entity rather than an individual?
- How does vesting work when the grantee is a company? Is it even standard to vest entity-held shares?
- Would the RSPA need fundamental restructuring, or just name/entity changes?
4. Securities Law
- Reg S vs Reg D considerations for issuing to a foreign entity?
- Any additional securities exemption requirements?
- Does issuing to an entity vs individual change the
Artifacts:
docs/entity-equity-research.md
FLIP Evaluation Results
Dimension scores:
- hallucination_rate: 0.00
- requirement_coverage: 0.45
- semantic_match: 0.85
- specificity_match: 0.25
Evaluator reasoning: The inferred version correctly identifies the core task—researching entity-vs-individual equity approaches for Singapore contexts—and captures high-level requirements (tax, legal, practical considerations, comparison, recommendations). However, it loses substantial specificity: missing are the named company (Poietic Inc, Delaware PBC), named individual (Vaughn Tan), specific context (follow-up to non-us-equity-research.md, addressing lack of US SSN), seven detailed question categories (corporate structure, Section 83(b), W-8BEN-E, FATCA, CFC/PFIC, governance, cap table), specific deliverable location and structure (docs/entity-equity-research.md with Q&A answers, comparison table, document modifications list, counsel assessment), and validation criteria. The inferred description is appropriately generic for a decision-maker, but lacks the granular research directives and structural requirements needed to execute the task. No hallucinations detected—all inferred elements are grounded in the actual task.
FLIP metadata: {"comparison_model":"claude-haiku-4-5-20251001","inference_model":"claude-sonnet-4-20250514","inferred_prompt":"Research and analyze the option of granting equity to a Singapore corporate entity instead of directly to individuals. Compare the two approaches (entity vs. individual grants) covering tax implications, legal/regulatory requirements, and practical considerations under Singapore law. Provide actionable recommendations on which approach would be preferable, including clear identification of risks, trade-offs, and caveats for each option. Output should be a comprehensive analysis document suitable for decision-making on international equity compensation structures."}
Verification Steps
Independently check whether the work was actually completed. Do NOT trust the original agent's claims.
- Check
git log --oneline -10for recent commits related to this task - Check
git diffto see if meaningful changes were made - Run
cargo build && cargo testto verify nothing is broken - Verify any artifacts mentioned in the task description exist
Repair & Verdict
- If everything looks good: log verification passed and mark this task done.
- If problems found: fix them directly — edit code, resolve test failures, correct logic errors, then run the verification again. Commit your fixes with a descriptive message. Once fixed, mark this task done.
- Only as a last resort, if the approach is fundamentally wrong and cannot be salvaged: run
wg fail 'research-equity-grant' --reason "FLIP verification failed: <reason>"then mark this task done.
Remember: your job is to make the work pass, not to find reasons to reject it.
Depends on
Required by
Log
- 2026-04-01T14:55:57.813681692+00:00 Spawned by coordinator --executor claude --model claude-opus-4-6
- 2026-04-01T14:56:06.359894093+00:00 Starting verification of research-equity-grant. Checking git history, artifacts, and content quality.
- 2026-04-01T14:57:10.005988865+00:00 Artifact docs/entity-equity-research.md exists (378 lines). Reviewing against task requirements.
- 2026-04-01T14:58:11.279192910+00:00 Gap found: CFC/PFIC analysis was entirely missing from original document. Added Section 2 subsection 'CFC and PFIC Analysis' with IRC references, risk assessment for Poietic, and economic substance cross-reference. Also improved tax treaty correction to explicitly reference prior research doc.
- 2026-04-01T14:58:19.083471003+00:00 Validation checklist: - [x] Corporate structure types (Pte Ltd, sole prop, etc): Section 1 - [x] Formation requirements: Section 1 - [x] Issues with SG entity holding US equity: Section 1 - [x] Entity vs individual tax differences: Section 2 + comparison table - [x] W-8BEN-E vs W-8BEN: Section 2 - [x] FATCA implications: Section 2 - [x] Withholding simplification/complication: Section 2 - [x] CFC/PFIC analysis: Section 2 (ADDED - was missing) - [x] Transfer pricing: Section 2 - [x] Section 83(b) for entities: Section 3 - [x] Vesting for entity grantee: Section 3 - [x] RSPA restructuring: Section 3 - [x] Reg S vs Reg D: Section 4 - [x] Securities exemption requirements: Section 4 - [x] Entity vs individual securities impact: Section 4 - [x] Comparison table: Section 7 - [x] Recommendation: Section 7 - [x] Professional counsel assessment: Section 8 - [x] Tax treaty correction noted: Executive summary
- 2026-04-01T14:58:39.340631886+00:00 Verification PASSED with repair. Original document was substantially correct and well-structured. One significant gap (CFC/PFIC analysis) was repaired by adding a new subsection. Tax treaty correction cross-reference improved. All task requirements now covered.
- 2026-04-01T14:58:42.548920157+00:00 Task marked as done